Great News For Gilead Sciences And HCV PatientsSeeking AlphaGilead submitted a New Drug Application [NDA] with the same Phase 3 trial data to the FDA in April 2013. The FDA has since issued a Form 483 letter questioning the company's test procedures, stability testing and laboratory controls regarding several ...http://seekingalpha.com/article/1465861-great-news-for-gilead-sciences-and-hcv-patients?source=google_news
No comments:
Post a Comment